Aethlon Medical Inc. (NASDAQ: AEMD) plunged 36.05% after announcing the signing of a definitive agreement with an institutional investor to acquire 1,380,555 of its common shares in a registered direct offering at $9 per share priced at-the-market.  Aethlon closes a $12 million direct offering.  The company anticipates closing the direct […]